Back to results
US 11,192,900 B2Granted
Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors
AssigneeNuvation Bio Inc.
InventorsSon Minh Pham, Sarvajit Chakravarty, Jayakanth Kankanala, Jiyun Chen, Anjan Kumar Nayak, Anup Barde
Life of this patent
Estimating the term…
Abstract
Novel bromodomain and extraterminal domain (BET) inhibitors contanining substituted 2-pyridones and therapeutic methods of treating conditions and diseases using these novel BET inhibitors are provided.
Claims25
A compound of Formula (I):
- or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing,
- wherein:
- Ra is hydrogen, halogen, or C1-C4 alkyl;
- Rb is hydrogen, halogen, cyano, C1-C4 alkyl, C1-C4 haloalkyl, C(O)NR10R11, NR10R11, NR10C(O)R11, NR10S(O)2R11, OR10, S(O)2R10, S(O)2NR10R11, C3-C6 cycloalkyl, or 3- to 6-membered heterocyclyl;
- Re is hydrogen, halogen, cyano, C1-C4 alkyl, or 3- to 6-membered heterocyclyl;
- R1 is hydrogen or C1-C4 alkyl, wherein the C1-C4 alkyl is optionally substituted by 1 or more OH substituents;
- R2 is hydrogen, halogen, cyano, C1-C4 alkyl, C1-C4 haloalkyl, C(O)NR10R11, NR10R11, NR10C(O)R11, NR10S(O)2R11, OC1-C4 alkyl, OC1-C4 haloalkyl, S(O)2R10, S(O)2NR10R11, C3-C6 cycloalkyl, or 3- to 6-membered heterocyclyl;
- R3 is hydrogen, halogen, cyano, C1-C4 alkyl, (CH2)mW3Rg, (CH2)mN(Rf)C(O)ORh, (CH2)mN(Rf)W3Rg, C(O)NR13R14, NR13R14, NR13C(O)R14, NR13C(O)NR13R14, NR13S(O)2R14, NR13S(O)2NR13R14, OR13, S(O)2R1, or S(O)2NR13R14, wherein the C1-C4 alkyl is optionally substituted by 1 or more substituents independently selected from the group consisting of oxo, halogen, cyano, and OH;
- R4 is hydrogen, (CH2)mW3Rg, or (CH2)mN(Rf)W3Rg;
- each W3 is independently —C(O)— or —S(O)2—;
- each Rf is independently hydrogen, C1-C4 alkyl, or C3-C6 cycloalkyl;
- each Rg is independently CRg1=CHRg2 or C≡CRg2;
- each Rg1 is independently hydrogen, cyano, or C1-C4 alkyl, wherein each C1-C4 alkyl is optionally and independently substituted by 1 or more substituents independently selected from the group consisting of NH2, NHCH3, N(CH3)2, OH, and OCH3;
- each Rg2 is independently hydrogen, cyano, or C1-C4 alkyl, wherein each C1-C4 alkyl is optionally and independently substituted by 1 or more substituents independently selected from the group consisting of NH2, NHCH3, N(CH3)2, OH, and OCH3;
- each Rh is independently C1-C6 alkyl or C3-C6 cycloalkyl;
- each R5 is independently hydrogen, halogen, cyano, C1-C4 alkyl, C(O)NR10R11, C(O)OR10, NR10R11, NR10C(O)R11, NR10S(O)2R11, OR10, S(O)2R10, S(O)2NR10R11, C3-C6 cycloalkyl, 3- to 6-membered heterocyclyl, C6-C14 aryl, or 5- to 10-membered heteroaryl, wherein each C1-C4 alkyl, C1-C4 haloalkyl, C(O)NR10R11, C(O)OR10, NR10R11, NR10C(O)R11, NR10S(O)2R11, OR10, S(O)2R10, S(O)2NR10R11, C3-C6 cycloalkyl, 3- to 6-membered heterocyclyl, C6-C14 aryl, and 5- to 10-membered heteroaryl is optionally and independently substituted by 1 or more independently selected R12 substituents;
- W1 is a bond, —NRw1—, or —O—;
- Rw1 is hydrogen, C1-C4 alkyl, or C3-C6 cycloalkyl, wherein the C1-C4 alkyl is optionally substituted by 1 or more substituents independently selected from the group consisting of halogen, oxo, and OH;
- Rc is hydrogen, halogen, cyano, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, 3- to 6-membered heterocyclyl, C6-C14 aryl, or 5- or 6-membered heteroaryl, wherein the C3-C6 cycloalkyl, 3- to 6-membered heterocyclyl, C6-C14 aryl, or 5- or 6-membered heteroaryl is optionally substituted by 1 or more independently selected Rc1 substituents;
- each Rc1 is independently oxo, halogen, cyano, C1-C4 alkyl, C1-C4 haloalkyl, C(O)NR10R11, NR10R11, NR10C(O)R11, NR10S(O)2R11, OR10, S(O)2R10, S(O)2NR10R11, C3-C6 cycloalkyl, or 3- to 6-membered heterocyclyl;
- W2 is a bond;
- Rd is hydrogen, C1-C4 alkyl, or 3- to 6-membered heterocyclyl;
- each R10 is independently hydrogen, C1-C4 alkyl, C1-C3 alkylene-C3-C6 cycloalkyl, C1-C3 alkylene-3- to 6-membered heterocyclyl, C2-C4 alkenyl, C(O)R12, C3-C6 cycloalkyl, or 3- to 6-membered heterocyclyl, wherein each C1-C4 alkyl is optionally and independently substituted by 1 or more substituents independently selected from the group consisting of oxo, halogen, cyano, C(O)NR13R14, NR13R14, and OH;
- each R11 is independently hydrogen, C1-C4 alkyl, C1-C3 alkylene-C3-C6 cycloalkyl, C1-C3 alkylene-3- to 6-membered heterocyclyl, C2-C4 alkenyl, C(O)R12, C3-C6 cycloalkyl, or 3- to 6-membered heterocyclyl, wherein each C1-C4 alkyl is optionally and independently substituted by 1 or more substituents independently selected from the group consisting of oxo, halogen, cyano, C(O)NR13R14, NR13R14, and OH;
- or
- each R10 and R11, taken together with the atoms to which they are attached, form a 3- to 6-membered heterocyclyl, wherein each 3- to 6-membered heterocyclyl is optionally and independently substituted by 1 or more substituents independently selected from the group consisting of oxo, halogen, cyano, C1-C4 alkyl, and OH, and further wherein each C1-C4 alkyl substituent is optionally and independently substituted by 1 or more substituents independently selected from the group consisting of oxo, halogen, cyano, and OH;
- each R12 is independently halogen, C1-C4 alkyl, C3-C6 cycloalkyl, or 3- to 6-membered heterocyclyl, wherein each C1-C4 alkyl is optionally and independently substituted by 1 or more substituents independently selected from the group consisting of oxo, halogen, cyano, NR 13R14, NR13C(O)R14, and OH;
- each R13 is independently hydrogen, C1-C4 alkyl, C3-C6 cycloalkyl, or 3- to 6-membered heterocyclyl, wherein each C1-C4 alkyl is optionally and independently substituted by 1 or more substituents independently selected from the group consisting of oxo, halogen, cyano, and OH;
- each R14 is independently hydrogen, C1-C4 alkyl, C3-C6 cycloalkyl, or 3- to 6-membered heterocyclyl, wherein each C1-C4 alkyl is optionally and independently substituted by 1 or more substituents independently selected from the group consisting of oxo, halogen, cyano, and OH;
- or
- each R13 and R14, taken together with the atoms to which they are attached, form a 3- to 6-membered heterocyclyl, wherein each 3- to 6-membered heterocyclyl is optionally and independently substituted by 1 or more substituents independently selected from the group consisting of oxo, halogen, cyano, C1-C4 alkyl, and OH, and further wherein each C1-C4 alkyl substituent is optionally and independently substituted by 1 or more substituents independently selected from the group consisting of oxo, halogen, cyano, and OH;
- and
- each m is independently 0, 1, 2, 3, or 4;
- with the proviso that at least one of R3 and R4 is (CH2)mW3R9 or (CH2)mN(Rf)W3Rg.
31 more elements
Dependencies are inferred from the claim text.